🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To compare the complete response rate (CR rate) after in...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-23
Trial ID
NCT07505849
Treatments Being Tested
In view of the synergistic effects of rituximab, zanubrutinib, and lenalido...
Status
Unknown
Location
Henan cancer hospital
Start Date
2021-05-26
Trial ID
NCT04938297
Treatments Being Tested
This is a prospective, open-label, multicenter, randomized controlled study...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2026-05-06
Trial ID
NCT07594899
The purpose of this study is to compare the efficacy and safety of genotype...
Status
Recruiting
Location
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Start Date
2025-04-01
Trial ID
NCT06803693
As the most common subtype of lymphoma, diffuse large B-cell lymphoma (DLBC...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2021-10-01
Trial ID
NCT05290090
Treatments Being Tested
The goal of this phase 2 trial is to test the safety and efficacy of Pola-Z...
Status
Recruiting
Location
Navy General Hospital
Start Date
2024-09-24
Trial ID
NCT06664411
This study is a multi-center, open-label, single-arm, non-randomized phase ...
Status
Unknown
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Start Date
2022-02-01
Trial ID
NCT05200312
A multicenter, prospective, randomized, open-label, controlled trial to eva...
Status
Recruiting
Location
Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2024-07-29
Trial ID
NCT06522555
This clinical trial is an investigator-initiated multicenter, open, prospec...
Status
Unknown
Location
Qingdao central Hospital
Start Date
2022-05-01
Trial ID
NCT05392257
Treatments Being Tested
The goal of this clinical trial is to learn if Zanubrutinib, Rituximab, and...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07299331